NBP NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

NovaBridge Biosciences · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 1.60 USD
-9.6% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -36.0% below the Trend Line and sits at 2.6% of its 52-week range. The latest completed week returned -9.6%, after a -25.2% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 54/100 conviction, while the latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal; earnings are due in 17d.

Setup score 18 out of 100
Latest Close 1.60 USD 31 Jul 2026
1W Return -9.6% latest completed week
4W Return -25.2% short-term follow-through
12W Return -27.3% quarterly tape
Trend Breadth 46.2% 24 of 52 weeks active
Volume Ratio 0.4x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -9.6% Latest completed week; four-week move -25.2%. Indicator stack 25/56 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 38.52% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 54/100 conviction; expected move 165.6%. News sentiment 50/100 52 relevant articles in the latest sentiment read. Event risk 17d Next report is scheduled for 19 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -36.0% below the Trend Line and sits at 2.6% of its 52-week range. The latest completed week returned -9.6%, after a -25.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0312-week average 0.01

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -25.2% over four weeks, -27.3% over 12 weeks, and -38.9% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-9.6%
4W-25.2%
12W-27.3%
26W-51.7%
52W-38.9%
Active trend streak0 weeks
Active weeks in one year24
Trend breadth46.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.07Latest activity-pressure read.
Pressure change93.7%Four-week change in activity pressure.
Leadership-56.03Latest relative-leadership reading.
RS change-26.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 64% Model confidence 61%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength48/100Blend of value, momentum, and quality. Underlying universe rank 53; rank 1 is best.
Value48/100Relative valuation strength. Underlying universe rank 53; rank 1 is best.
Quality47/100Profitability and accounting quality. Underlying universe rank 54; rank 1 is best.
Momentum49/100Medium-term price momentum. Underlying universe rank 52; rank 1 is best.
Growth49/100Revenue and earnings growth. Underlying universe rank 52; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-11.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-2234.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-30.1%
Net share repurchases relative to market value.
Shareholder yield
-30.1%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

NBP shows volatility options pressure with a 54/100 conviction score, put-call volume ratio of 0.00, expected move of 165.6%, and Sharemaestro trend signal inactive.

Conviction54/100
Expected move165.6%
Put/call volume0.00
Pressure100
Speculation9
Volatility96
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 52 relevant articles.

9 positive · 37 neutral · 6 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings17dNext report is scheduled for 19 Aug 2026; event risk rises as the date approaches.
Options expected move165.6%Nearest-chain priced movement where available.
52-week drawdown-76.4%Distance below the 52-week high.
13-week volatility11.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher8 of 2618 weeks finished lower.
Best week+30.5%Week of 3 Jul.
Worst week-19.1%Week of 13 Mar.
Latest week-9.6%Week of 31 Jul.

Shape of recent returns

Strong gains5
Modest gains3
Flat weeks0
Modest losses6
Sharp losses12
Recent vol11.7%13-week weekly-return volatility.
Base vol13.5%52-week weekly-return volatility.
Up/down split23/29Count of positive and negative weeks in the 52-week window.
Average skew11.5% / -9.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape22/100

Trend, activity pressure, participation, and risk combine to a 22/100 tape read.

 Indicator analysis11/100

Latest 12-week confirmation: trend 0/12, activity pressure 1/12, relative leadership 0/12.

Activity pressure 0.03; No reversal markers Next-Week ExpectancyNegative 38.52%

Next-week expectancy is negative with a 38.52% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors47/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 93; Small Cap Core rank 55 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options36/100

NBP shows volatility options pressure with a 54/100 conviction score, put-call volume ratio of 0.00, expected move of 165.6%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 165.6% Sentiment50/100

Weighted news tone is neutral across 52 relevant articles.

Novabridge Biosciences ADR (NBP) Dividends & Stock Splits: Historical Payouts and Event Timeline Insiders50/100

No recent insider transaction evidence is stored.

 Earnings17d

Next report is scheduled for 19 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20261.60 USD-9.6%2.50 USD2.06 USD-0.07-56.031.1MOff
24 Jul 20261.77 USD-0.6%2.59 USD2.07 USD0.13-51.521.5MOff
17 Jul 20261.78 USD-6.3%2.67 USD2.08 USD-0.15-52.221.5MOff
10 Jul 20261.90 USD-11.2%2.75 USD2.09 USD-0.60-51.333.8MOff
3 Jul 20262.14 USD30.5%2.82 USD2.09 USD-1.17-44.447.6MOff
26 Jun 20261.64 USD9.3%2.89 USD2.10 USD-1.84-57.191.3MOff
19 Jun 20261.50 USD0.7%2.96 USD2.10 USD-2.03-62.922.6MOff
12 Jun 20261.49 USD-9.4%3.06 USD2.11 USD-2.05-62.542.1MOff
5 Jun 20261.65 USD-10.6%3.14 USD2.12 USD-2.03-58.082.8MOff
29 May 20261.84 USD4.0%3.22 USD2.13 USD-1.90-55.582.5MOff
22 May 20261.77 USD-2.7%3.33 USD2.14 USD-1.74-56.044.8MOff
15 May 20261.82 USD-17.3%3.41 USD2.15 USD-1.71-54.174.5MOff
8 May 20262.20 USD-7.6%3.54 USD2.16 USD-1.52-44.625.6MOff
1 May 20262.38 USD-2.9%3.63 USD2.16 USD-1.65-36.5110.3MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.